 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/12/2024 |
$145.00 |
$146.81 |
$140.08 |
$141.30 |
139.50K | | 04/15/2024 |
$140.68 |
$142.63 |
$137.38 |
$138.40 |
228.20K | | 04/16/2024 |
$137.28 |
$137.71 |
$133.71 |
$134.05 |
309.00K | | 04/17/2024 |
$134.40 |
$134.40 |
$131.28 |
$131.86 |
200.10K | | 04/18/2024 |
$131.40 |
$136.00 |
$131.40 |
$131.96 |
126.00K |
|
|
| BeiGene is a commercial-stage biotechnology company focused on developing and commercializing molecularly-targeted and immuno-oncology cancer therapeutics. Co.'s clinical-stage drug candidates include: Zanubrutinib, which is a small molecule inhibitor of Bruton's tyrosine kinase for the treatment of mantle cell lymphoma in adult patients; Tislelizumab, which is a humanized monoclonal antibody against the immune checkpoint receptor programmed cell death protein 1; Pamiparib (BGB-290), which is for the treatment of various solid tumors; and Lifirafenib, which is an investigational small molecule inhibitor with RAF monomer and dimer inhibition activities. | |
|
BeiGene (BGNE) has the following price history information. Looking back at BGNE historical stock prices for the last five trading days, on April 12, 2024, BGNE opened at $145.00, traded as high as $146.81 and as low as $140.08, and closed at $141.30. Trading volume was a total of 139.50K shares. On April 15, 2024, BGNE opened at $140.68, traded as high as $142.63 and as low as $137.38, and closed at $138.40. Trading volume was a total of 228.20K shares. On April 16, 2024, BGNE opened at $137.28, traded as high as $137.71 and as low as $133.71, and closed at $134.05. Trading volume was a total of 309.00K shares. On April 17, 2024, BGNE opened at $134.40, traded as high as $134.40 and as low as $131.28, and closed at $131.86. Trading volume was a total of 200.10K shares. On April 18, 2024, BGNE opened at $131.40, traded as high as $136.00 and as low as $131.40, and closed at $131.96. Trading volume was a total of 126.00K shares.
BGNE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into BeiGene shares, starting with a $10,000 purchase of BGNE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/05/2016 |
|
| End date: |
04/18/2024 |
|
| Start price/share: |
$33.91 |
|
| End price/share: |
$131.96 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
289.15% |
|
| Average Annual Total Return: |
18.02% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$38,925.41 |
|
| Years: |
8.20 |
|
|
|
| Date |
Close |
| 04/12/2024 | $141.30 | | 04/15/2024 | $138.40 | | 04/16/2024 | $134.05 | | 04/17/2024 | $131.86 | | 04/18/2024 | $131.96 |
|
|
